Doud­na-found­ed CRISPR up­start bags $45M for new Cas re­search, ex­tends its reach in­to ther­a­peu­tics

The South San Fran­cis­co-based CRISPR up­start that set out to de­vel­op di­ag­nos­tics un­der co-founder Jen­nifer Doud­na’s guid­ance is back with $45 mil­lion in fund­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER